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The dihydrofolate reductase (DHFR) gene encodes an enzyme important for metabolism and cell growth. We
have found multiple DNA-protein interactions within the hamster DHFR gene promoter in vitro. These
interactions occur over the consensus binding sites for two eucaryotic transcription factors, Spl and E2F. The
DHFR E2F consensus site possesses a dyad symmetry and is unique in its location immediately 3' to the major
transcription start site. The interaction of E2F with the DHFR promoter has been detected in HeLa nuclear
extracts, confirmed by using partially purified E2F, and characterized by both enzymatic and chemical assays
of the DNA-protein interaction. A mutation of the E2F recognition sequence which abolishes E2F binding to the
DHFR promoter results in a two- to fivefold decrease of in vitro transcriptional activity and a fivefold reduction
of DHFR promoter activity in transient-expression assays. Thus, the interaction of E2F with the DHFR
promoter is required for efficient expression of the DHFR gene.
Dihydrofolate reductase (DHFR) is a metabolic enzyme
involved in the synthesis of purines, thymidylate, and gly-
cine (23). It is considered a housekeeping enzyme, since it is
found in small amounts in nearly all cell types and is required
for cell growth (21). Although the gene encoding DHFR is
widely expressed, this expression is influenced by several
factors, including the growth state of the cells, the cell cycle,
and the presence of viral infection (6, 21, 27). The DHFR
promoter lacks TATAA and CCAAT DNA sequence motifs,
which are regulatory sequence elements found in most
eucaryotic promoters transcribed by RNA polymerase II.
The DHFR promoter contains multiple copies of GC boxes,
which are capable of interacting with the transcription factor
Spl (5). An additional conserved sequence including the
major transcription start site has been identified in the
DHFR promoter (1).
The eucaryotic transcription factor E2F was originally
identified as a DNA-binding activity in HeLa nuclear ex-
tracts (12). This factor binds to two sites in a region of the
adenovirus E2 promoter known to be required for E2 pro-
moter activity. E2F binding activity increases upon infection
of HeLa cells with wild-type adenovirus; this increase de-
pends on the presence of a functional EIA gene (12). The
adenovirus ElA gene product is known to trans-activate
several viral and cellular genes by a variety of mechanisms.
E2F is hypothesized to be one of the targets of the adeno-
virus ElA gene product early in adenovirus infection. E2F
binding sites have also been identified in the ElA enhancer
(13) and the c-myc promoter (10, 24); E2F binds to the
sequence 5'-TTTCGCGC-3'. DHFR expression is increased
by adenovirus infection, although the molecular level at
which this increase occurs is unclear (7, 27).
One study of the mouse DHFR promoter reported that a
fraction of HeLa nuclear extract enriched in Spl bound to
the consensus Spl binding sites in the mouse DHFR pro-
moter (5). It also showed that HeLa nuclear extracts de-
pleted of this fraction were incapable of efficient in vitro
transcription (5). We report here that an additional factor in
HeLa nuclear extracts binds to the hamster DHFR promoter
* Corresponding author.
in vitro and is required for efficient DHFR expression both in
vitro and in vivo. This additional factor appears to be E2F on
the basis of its recognition sequence, the comigration of
DNA-protein complexes generated in nuclear extracts with
those generated by using partially purified E2F, footprinting
and methylation interference patterns, and loss of binding
after a specific site-directed mutation. The data presented
include the mapping of DNA-protein interactions occurring
within a DHFR promoter construct known to have transcrip-
tional activity in vitro and in vivo and characterization of the
interaction of E2F with the DHFR promoter by DNA-
binding assays and site-directed mutagenesis, followed by
functional analysis of the role of E2F in DHFR expression.
(This work was conducted by M.C.B. in partial fulfillment
of the requirements for the Ph.D. degree from the University
of North Carolina, Chapel Hill.)
MATERIALS AND METHODS
Preparation of nuclear extracts. HeLa-S3 cells were grown
in suspension culture and maintained at a density of 4 x 105
to 8 x 105 cells per ml in Joklik modified essential medium
supplemented with 10% defined calf serum (Hyclone Labo-
ratories, Inc.) and gentamycin-kanamycin. Nuclear extracts
were prepared from these cells by an established method (4)
with the following modifications. After homogenization of
cells in hypotonic medium, nuclei were recovered by cen-
trifugation at 30,000 x g for 30 s. Nuclei were then extracted
in buffer C [20 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES; pH 7.9), 0.2 mM EDTA, 0.2
mM ethylene glycol-bis(P-aminoethyl ether)-N,N,N',N'-tet-
raacetic acid (EGTA), 2 mM dithiothreitol (DTT), 25%
glycerol, 0.15 mm spermine, 0.75 mM spermidine, 1 mM
phenylmethylsulfonyl fluoride, 0.4 M NaClI]. The extract
was recovered by centrifugation at 150,000 x g for 90 min
followed by dialysis against modified buffer D (20 mM
HEPES [pH 7.9], 20% glycerol, 100 mM KCI, 0.2 mM
EDTA, 0.2 mM EGTA, 2 mM DTT, 1.0 mM phenylmethyl-
sulfonyl fluoride, 12.5 mM MgCl2). The extract was stored in
aliquots at -70°C.
DNase I footprinting. DNase I footprinting was carried out
by a modification of the standard technique (8). Typically, 5
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to 10 ng of end-labeled DNA was incubated with various
amounts of nuclear extract protein in the presence of 15 ,ug
of poly(dI-dC) in a 120-,ul reaction volume containing 6.1%
glycerol, 0.07 mM EDTA, 0.07 mM EGTA, 7.2 mM HEPES
(pH 7.9), 39 mM KCI, and 7.5 mM MgCl2. The binding
reactions were incubated at room temperature for 30 min and
adjusted to a final CaCl2 concentration of 2 mM. Freshly
diluted DNase I (Bethesda Research Laboratories, Inc.) was
added to the reactions, and digestion was allowed to proceed
for 4 min at room temperature. Digestion was stopped by
adding 2 volumes of a mixture containing 100 mM Tris
hydrochloride (pH 8.0), 100 mM NaCl, 20 mM EDTA (pH
8.0), 0.1% sodium dodecyl sulfate, 100 ,ug of proteinase K
per ml, and 100 ,ug of tRNA per ml. Following incubation at
37°C for 20 min, the samples were extracted with an equal
volume of phenol-chloroform (phenol-chloroform-isoamyl
alcohol, 25:24: 1) and ethanol precipitated. The samples were
suspended in 7 M urea-dye mix and electrophoresed through
8% polyacrylamide gels (acrylamide-bisacrylamide, 19:1) in
0.5x TBE buffer (0.045 M Tris, 0.045 M boric acid, 1 mM
disodium EDTA). The gels were exposed to X-ray film
overnight at -70°C with an intensifying screen.
Gel mobility shift assays. Gel retardation assays were
performed under previously reported conditions for E2F
(26). Reaction mixtures consisted of 0.1 to 0.3 ng of labeled
promoter fragment and 6 jig of HeLa nuclear extract protein
in a buffer consisting of 20 mM HEPES (pH 7.9), 40 mM
KCl, 1 mM MgCl2, 0.4 mM DTT, 0.08 mM EGTA, 4% Ficoll
(Pharmacia Fine Chemicals), and 0.04% Nonidet P-40.
Salmon sperm DNA (2 ,ug) was added as nonspecific com-
petitor DNA, and the final volume of the reaction mixtures
was adjusted to 25 RI. Following incubation at room temper-
ature for 30 min, the reactions were loaded onto a 4%
polyacrylamide gel (acrylamide-bisacrylamide, 30:0.8) in
0.25x TBE and electrophoresed at 250 V for 1 to 2 h. The
gels were exposed to X-ray film overnight at -70°C with an
intensifying screen.
MPE footprinting. Methidiumpropyl-EDTA-Fe(II) (MPE)
footprinting was carried out as described previously (15).
Briefly, preparative gel shift reactions were incubated at
room temperature for 30 min, at which time a calculated
volume of a mixture containing 500 puM MPE, 500 ,uM
Fe(NH4)2(SO4)2, and 20 mM DTT was added to the binding
reactions (final concentrations, 100 ,uM MPE, 100 pIM
Fe(NH4)2(SO4)2, and 4 mM DTT). The reactions were then
loaded and electrophoresed as normal, with 10 min allowed
for the digestions to proceed prior to electrophoresis. Fol-
lowing brief autoradiography, the bands corresponding to
the major E2F complex and free probe were isolated and the
DNA was electrophoresed through 1% agarose gels onto
NA45 paper (Schleicher & Schuell Inc.). The DNA was then
eluted, phenol-chloroform extracted, and ethanol precip-
itated. The resulting partial cleavage ladders were resolved
on 8% sequencing gels and autoradiographed at -70°C.
Methylation interference assays. Partially methylated
probe DNA was prepared by treating end-labeled probe
DNA with dimethyl sulfate as described previously (16).
This DNA was used in preparative gel shift reactions, which
were loaded and electrophoresed as normal. The bands
corresponding to the major E2F complex, minor E2F com-
plex, and free probe were excised and processed as for MPE
footprinting, except that the samples were cleaved with
piperidine prior to electrophoresis.
Oligonucleotide-directed mutagenesis of the DHFR E2F site.
A mutant with a mutation in the DHFR E2F consensus
binding site was constructed by oligonucleotide-directed
mutagenesis (14). To construct this mutant, a DHFR pro-
moter fragment containing DHFR sequences from -239 to
-22 was subcloned into M13mpl8, and the resultant bacte-
riophage was passaged through Escherichia coli CJ236 (ob-
tained from T. Kunkel, National Institute of Environmental
Health Sciences), which is deficient in uracil-N-glycosylase
and dUTPase activity (11). Uracil-containing single-stranded
DNA was then purified and used as a template for second-
strand synthesis by using a mutagenic oligonucleotide
of the sequence 5'-TGCAATTTCGTACCAAACTTG-3',
which bears a 2-base mismatch (underlined) with the wild-
type DHFR E2F consensus sequence. Briefly, 10 ng of the
mutagenic primer was annealed to 200 ng of -239 template
DNA, and second-strand synthesis was initiated by the
addition of T4 DNA ligase (Boehringer Mannheim Biochem-
icals) and modified T7 DNA polymerase (Sequenase; U.S.
Biochemical Corp.) to the reaction in a volume of 20 ,ul (final
buffer conditions, 20 mM Tris [pH 7.5], 10 mM MgCl2/50
mM NaCl, 6.7 mM DTT, 1 mM ATP, 0.4 mM dATP, 0.4 mM
dGTP, 0.4 mM dCTP, and 0.4 mM dTTP). Transformation of
the synthesis products into E. coli DH5aF' (Bethesda Re-
search Laboratories) allowed for the production of plaques,
which were then screened for the mutation by DNA se-
quencing via the chain termination method (20).
In vitro transcription assays. In vitro transcription reac-
tions were performed in a final volume of 25 pl containing
400 puM ATP, 400 ,uM CTP, 400 puM UTP, 50 ,uM [a-32P]GTP
(3,000 Ci/mmol; 10 ,Ci per reaction), 1 mM creatine phos-
phate, and 140 puM EDTA. The transcription reactions were
initiated by the addition of linearized plasmid template DNA
and 15 ,lI of nuclear extract (150 pug of protein). The
reactions were incubated at 30°C for 60 min and stopped by
the addition of a mixture containing 8 M urea, sodium
dodecyl sulfate, 0.5% 10 mM EDTA, and 10 mM Tris (pH
8.0). A 494-nucleotide Sp6 transcript was included in the
stop mixture as a control for sample recovery during proc-
essing. The samples were phenol-chloroform extracted
twice, ethanol precipitated, and electrophoresed on 4%
polyacrylamide-7 M urea denaturing gels in 0.5x TBE.
Autoradiography was performed as described above.
Transient-expression assays of DHFR expression. HeLa
cells were maintained in monolayer in Eagle minimal essen-
tial medium supplemented with 10% defined calf serum
(Hyclone). The -239 and -239 mutant constructs were
transfected into HeLa cells by the calcium phosphate copre-
cipitation method (9). Plasmid DNA (10 pug) was precipitated
for 30 min in HEPES-buffered saline by the addition of CaCI2
to 6.0 mM. The DNA precipitate in 500 plI was layered onto
a washed, well-drained monolayer containing ca. 106 cells
per 10-cm dish. Complete medium was added after 30 min.
After 4 hours, the medium was aspirated and the cells were
treated with 12.5% glycerol in HEPES-buffered saline for 4
min; the monolayer was then washed and complete medium
was added. The cells were incubated for 48 h before being
harvested. Freeze-thaw lysates were assayed for protein
content by the Bradford method (2), and samples normalized
for protein content were assayed for chloramphenicol ace-
tyltransferase activity by using ['4Clchloramphenicol as a
substrate. Acetylated ["4C]chloramphenicol was separated
from the nonacetylated forms by thin-layer chromatography,
and the thin-layer chromatography plate was autoradio-
graphed. The percentage conversion of chloramphenicol to
acetylated chloramphenicol was determined by liquid scin-
tillation counting of isolated spots from thin-layer chroma-
tography plates.
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RESULTS
Multiple DNA-protein interactions within the DHFR 5'-
flanking region. Initial studies of the transcriptional activity
of a series of DHFR promoter deletion constructs indicated
that a construct containing from -239 to -23 relative to
ATG maximally expresses DHFR in vitro and in vivo, while
a construct containing from -103 to -18 has no transcrip-
tional activity (A. Swick, M. Blake, J. Kahn, and J. C.
Azizkhan, submitted for publication). The differences in
promoter activity displayed by progressive deletions of the
DHFR promoter suggested that the amount of 5'-flanking
sequence affects the efficiency of DHFR transcription. All of
the numbering of the DHFR 5'-flanking region is relative to
ATG, since the hamster DHFR gene contains a major and
minor transcription start site at positions -63 and -107,
respectively (18).
In an attempt to correlate protein-DNA interactions within
the DHFR 5'-flanking region with promoter activity, a frag-
ment from the BssHII site at -239 to the StyI site at -23 was
mapped by DNase I footprinting. Figure 1 shows the results
of a protein titration of HeLa nuclear extract on this frag-
ment. Three regions of protein-DNA interaction are seen on
the lower (noncoding) strand of the -239 promoter frag-
ment. Region 1 overlies the major transcription start site and
is evidenced by shifts in DNase I-hypersensitive sites from
-46 and -70 in the free DNA reaction to -49 and -66 in the
DNA-protein reaction. Region 2 is a footprint extending
from -95 to -115 and includes a GC box overlying the
DHFR secondary transcription start site at -107. Region 3 is
a footprint extending from -136 to -201 and includes three
GC boxes (part of this region is not included in Fig. 1 so that
the interaction in region 1 can be seen). The observed shift in
DNase I-hypersensitive sites in the region overlying the
major transcription start site lies within a conserved se-
quence previously reported as "element 2" (1) and requires
240 ,ug of nuclear extract protein under these conditions,
which is 4 times the amount of protein required to footprint
the GC boxes. We wish to note a correction in the published
hamster DHFR sequence; the nucleotide at position -68 is C
rather than the A previously reported (1).
DNase I analysis of the region from -50 to -65 is seen
more clearly in Fig. 2, in which a shorter probe lacking the
GC box motifs (from the HaeIII site at -103 to the Sau3AI
site at -19) is used. The sequence between the hypersensi-
tive sites at -49 and -66, 5'-CAATTTCGCGCCAAAC-3',
corresponds to two potential overlapping binding sites for
the cellular transcription factor E2F (Fig. 2, bottom). An
E2F binding site, 5'-TTTCGCGC-3', appears in the DHFR
promoter from -62 to -55. A seven-of-eight-nucleotide
match to this sequence, 5'-TTTGGCGC-3', is found from
positions -58 to -51 on the lower strand (Fig. 2, bottom);
this sequence is also capable of binding E2F (S. W. Hiebert,
J. Nevins, M. Blake, and J. C. Azizkhan, unpublished data).
The DNase I cleavage in this region is remarkably hindered
even in the absence of protein (Fig. 2, middle two lanes),
suggesting that this sequence forms a secondary structure
that is resistant to DNase I digestion. For the purposes of
analysis, we have designated the two recognition sequences
as site 1 and site 2, although it is not entirely clear that both
of these sites are functional. Since they are overlapping, we
will refer to the two overlapping recognition sites for the
transcription factor E2F in the DHFR promoter collectively
as the E2F site. A comparison of the DHFR E2F site with
other reported E2F sites is shown in Table 1. The E2, ElA,













FIG. 1. Multiple protein-DNA associations on the DHFR pro-
moter in vitro. An EcoRI-PstI fragment containing from -239 to
-23 of the DHFR promoter was asymmetrically end labeled on the
lower strand by a Klenow fill-in reaction, and 5 ng of the resulting
probe was incubated with 15 jig of poly(dI-dC) and various amounts
of HeLa nuclear extract as described in Materials and Methods.
Nucleotide positions of the interactions are noted on the side of the
diagram by boxes. Lanes 1 to 8 contain 0, 7.5, 15, 30, 60, 120, 240,
and 480 j±g of nuclear extract protein, respectively. DNase I
concentrations used in lanes 1 to 8 were 0.01, 0.06, 0.13, 0.25, 0.5,
1, 2, and 4 pug/ml, respectively. An expanded view of the sequence
contained in boxed region 1 is shown in Fig. 2.
binding sites. The DHFR site differs from the other sites in
its location 3' to the major DHFR transcription start site and
in the fact that either there is only one site or the two sites
are not tandemly arranged. One of the reported E2F sites
(ElA site 1) possesses a similar dyad symmetry to the DHFR
E2F site (Table 1).
A specific gel shift pattern is given by E2F in HeLa nuclear
extracts with the DHFR promoter. To confirm that the
interaction seen in this region was due to E2F, we used gel
shift assays. The -103 promoter fragment was chosen for a
study of the interaction of E2F with the DHFR promoter,
since it contains no GC boxes and could be more clearly
resolved. As a positive control for the interaction of E2F
MOL. CELL. BIOL.





















FIG. 2. Two shifts in DNase I-hypersensitive sites border a
potential E2F binding site in the DHFR promoter. An EcoRI-PstI
fragment containing from -103 to -17 of the DHFR promoter was
asymmetrically labeled on the lower strand by a Klenow fill-in
reaction, and 2 ng of the resulting probe was incubated with 15 ,ug of
poly(dI-dC) and either no protein (lanes -) or 240 jg of HeLa
nuclear extract protein (lane +) as described in Materials and
Methods. The sequence bordered by the DNase I-hypersensitive
sites at -49 and -66 is presented on the right side of the figure. Lane
G is a G ladder marker (16), lanes - are free DNA (DNase I
concentration of 0.01 ,Lg/ml), and lane + represents the DNA-plus-
protein reaction (DNase I concentration, ,ug/ml). The diagram below
the figure shows the sequence of the potential DHFR E2F site, with
the E2F consensus binding sequences indicated by brackets.
with the -103 promoter fragment, a gel shift reaction was
performed by using partially purified E2F isolated from
adenovirus-infected HeLa cells (the kind gift of J. Nevins,
Duke University) under conditions of low Mg2+ as described
previously (26). Incubation of 1 ,ul of partially purified E2F
with this fragment resulted in the formation of both a major
and a minor complex (Fig. 3, lane b). Incubation of the -103
promoter fragment with crude nuclear HeLa extract resulted
in the formation of multiple complexes, including complexes
comigrating with those formed with partially purified E2F
(Fig. 3, lanes c and d). Two additional complexes were
detected in our gel shift assays with crude nuclear extracts;
the lowest complex was not reproducibly seen in our assays
and may be nonspecific. The complex migrating above the
E2F complexes was not inhibited by a DHFR E2F site
oligonucleotide (see Fig. 6) and is also thought to be non-
specific.
Fine-scale mapping of the interaction of E2F with the DHFR
promoter by MPE-Fe(II) footprinting and methylation inter-
ference analysis. To further delineate the interaction of E2F
with the DHFR promoter, we used MPE footprinting (15).
MPE and other methods of chemical footprinting offer the
advantage of a smaller cleavage probe with less sequence
specificity than DNase I for protection experiments. More-
over, MPE does not have a functional requirement for Mg2+,
which inhibits the formation of E2F complexes in our gel
retardation assays. Indeed, the inclusion of 7.5 mM MgCl2 in
the DNase I footprinting reactions probably inhibited the
binding of E2F to the DHFR promoter, thus explaining the
large amount of nuclear extract protein required to generate
the observed shifts in DNase I hypersensitivity. MPE (kind-
ly supplied by P. Dervan, California Institute of Technology)
was used to partially cleave binding reactions, which were
then electrophoresed on native 4% polyacrylamide gels.
Bands corresponding to the free DNA and bound complexes
were then excised, and the resulting cleavage products were
resolved on sequencing gels. The MPE footprinting analysis
of the DHFR promoter (from -103) is presented in Fig. 4.
The region of the DHFR promoter protected from MPE
cleavage in the major E2F complex extends from -63 to -49
on the upper strand and from -51 to -64 on the lower
strand. The footprint includes the entire DHFR E2F site.
Methylation interference analysis of the shifted bands
corresponding to the major and minor E2F complexes re-
sulted in an interference pattern centered about the E2F
consensus on both strands, indicating G residues that, when
methylated, interfere with E2F binding to the DHFR pro-
moter. Figure 5 shows the methylation interference patterns
obtained on the upper and lower strands. The upper strand
contains two G residues within the E2F site that interfere
with E2F binding when methylated. On the lower strand,
four G residues within the footprinted region interfere with
binding when methylated. The methylation interference pat-
tern on the lower strand includes an additional G residue at
-54 that is not contained within the E2F consensus binding
site on the upper strand, suggesting that E2F is in close
proximity to this G residue when bound. Methylation of a G
residue at -59 interferes with E2F binding, although not as
completely as methylation of the other G residues in the
binding site does. The same methylation interference pattern
is displayed by the major and minor E2F complexes. The
lower portion of Fig. 5 shows a schematic diagram of the
regions protected by MPE footprinting, along with the
methylation interference patterns of both strands.
Analysis of a mutation which abolishes the interaction of
E2F with the DHFR promoter in vitro. Further evidence of
the interaction of E2F with the DHFR promoter was pro-
vided by the analysis of a specific mutation which abolishes
the DHFR E2F binding site. Oligonucleotides were synthe-
sized that contained both the wild-type DHFR E2F binding
site and a mutant DHFR E2F binding site. This mutation
changes the sequence at nucleotide positions -62 to -51
from 5'-TTTCGCGCCAAA-3' to 5'-TTTCGTACCAAA-3'
(substitution underlined), simultaneously abolishing both
potential overlapping E2F sites. Annealed wild-type and
mutant oligonucleotides were then examined for their ability
to compete for the E2F complexes generated in the gel shift
assay by using HeLa nuclear extract (Fig. 6). Although the
wild-type oligonucleotide completed for the major and minor
E2F complexes at a 25-fold molar excess, the mutant oligo-
nucleotide failed to compete for complex formation, even
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TABLE 1. Summary of E2F recognition sequences and location
Gene Promoter Location of interactiona Sequence Reference
E2 I -43 to -36 5'-GCGCGAAA-3' 12
3'-CGCGCTTT-5'
II -67 to -60 5'-TTTCGCGC-3'
3'-AAAGCGCG-5'
ElA enhancer I -224 to -217 5'-TTTCGCGGGAAA-3' 13
3'-AAAGCGCCCTTT-5'
II -287 to -280 5'-TTTCGCGC-3'
3'-AAAGCGCG-5'
c-myc (P2) I -42 to -35 5 -GATCGCGC-3Pb 10, 24
3'-CTAGCGCG-5'
II -65 to -58 5'-GCGGGAAA-3'
3'-CGCCCTfT-5'
DHFR +2 to +13 5'-TTTCGCGCCAAA-3'
3'-AAAGCGCGGTTT-5'
Consensus binding site 5'-TTT(C/G)(G/C)CG(C/G)-3'
aAll numbering is relative to the major start of transcription.
b Weak binding site.
under conditions of 200-fold molar excess. An additional
complex migrating above the E2F complexes was not com-
peted for by either oligonucleotide and is thought to be
nonspecific.
E2F is required for efficient DHFR transcription in vitro. To
h -
S. ..I_,_
FIG. 3. Complexes comigrating with partially purified E2F are
formed on the DHFR promoter in HeLa crude nuclear extracts. The
-103 to -17 DHFR promoter fragment was end labeled and
incubated alone (lane a), with 1 pLl of partially pure E2F (lane b), or
6 ,ug of HeLa crude nuclear extract (lanes c and d). Lanes b and d
contain 1 p.g of salmon sperm DNA as a nonspecific competitor; lane
c contains 2 ,ug of salmon sperm DNA. The major (I) and minor (II)
complexes of E2F with the DHFR promoter are noted on the side of
the figure. Additional complexes seen in lanes c and d are not due to
the E2F interaction and are addressed in the text.
assess the functional significance of the interaction of E2F
with the DHFR promoter, we used oligonucleotide-directed
mutagenesis to construct a site-directed mutant bearing the
above sequence alteration in the -239 DHFR promoter




































FIG. 4. MPE footprinting analysis of the major E2F complex
with the DHFR promoter. The -103 to -17 DHFR promoter
fragment was digested with KpnI-HindIII or EcoRI-PstI to selec-
tively label the upper and the lower strand, respectively. These
probes were then used in binding reactions with HeLa nuclear
extract. These reactions were partially digested with MPE and
separated on 4% native polyacrylamide gels. Shifted bands corre-
sponding to the major E2F complex on the upper strand or the lower
strand were excised from the gels. DNA from the complexes and the
free probe bands was then eluted and resolved on 8% sequencing
gels. Protected regions of the promoter are indicated by the DNA
sequence.
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FIG. 5. Methylation interference analysis of the major and minor
E2F complexes with the DHFR promoter. The -103 to -17 DHFR
promoter fragment was digested with KpnI-HindIII or EcoRI-PstI to
selectively label the upper and the lower strand, respectively. The
probe DNA was then partially methylated with dimethyl sulfate as
described previously (16). These probes were used in binding
reactions with HeLa nuclear extract and electrophoresed on 4%
native polyacrylamide gels. Shifted bands corresponding to the
major and minor E2F complexes on the upper strand or the lower
strand were excised from the gels, as well as bands corresponding to
the free probe DNA. DNA eluted from the bands was cleaved with
piperidine and resolved on 8% sequencing gels. G residues that
interfere with complex formation when methylated are indicated by
asterisks.
mutant does not bind partially purified E2F in the gel shift
assay when introduced into the -239 promoter construct
(data not shown).
The activity of the E2F mutant DHFR promoter, which
does not bind E2F, was compared with that of the wild-type
-239 construct in assays of transcriptional activity in vitro
by using HeLa nuclear extracts (Fig. 7). The two RNA
transcripts shown represent both the major DHFR transcrip-
tion start site (-63) and the minor start site (-107), which
have been reported previously (18). A 494-base transcript
was included as a control for sample recovery. In three
separate experiments with duplicate samples, transcription
I
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FIG. 6. The E2F complexes on the DHFR promoter are specif-
ically competed for by the wild-type DHFR E2F binding site but not
by a mutant DHFR E2F binding site. Binding reactions of HeLa
nuclear extract were preincubated with annealed oligonucleotides
bearing either a wild-type DHFR E2F binding sequence, (5'-
lTTCGCGCCAAA-3') or a mutant DHFR E2F binding sequence
(5'-TTTCGTACCAAA-3') for 10 min prior to the addition of end-
labeled -103 promoter fragment. The molar excess of competitor
DNA is indicated above each lane. (A) Lanes: F, free probe; Ox, no
competitor; 25 x through 200x, competition with wild-type oligonu-
cleotide. (B) Competition with mutant oligonucleotide.
from the mutant template was reduced two- to fivefold when
compared with that of the wild-type template. It should be
noted that the relative transcription from the major and the
minor start sites (4:1) appears to remain the same and that
the major start site of transcription is not preceptibly altered,
even though the E2F interaction occurs immediately 3' to
the major DHFR transcription start site at -63.
E2F is required for efficient DHFR expression in vivo.
Transient-expression assays were used to examine the ef-
fects of abolishing E2F binding in vivo (Fig. 8). Constructs
bearing the wild-type -239 construct or mutant -239 DHFR
construct fused to the bacterial chloramphenicol acetyltrans-
ferase gene were introduced into HeLa cells via the calcium
phosphate coprecipitation method of transfection. Compar-
ison of the relative chloramphenicol acetyltransferase activ-
ity of the wild-type versus the mutant construct in multiple
experiments indicates a greater than fivefold reduction (5.26
± 1.14 [standard error of the mean]; n = 7) in chloramphen-
icol acetyltransferase activity as measured by the percent
conversion of the nonacetylated to the acetylated form.
These results are consistent with the in vitro transcription
data and demonstrate the importance of the E2F interaction
in DHFR expression.
DISCUSSION
The data presented in this paper demonstrate that multiple
protein-DNA interactions occur in the immediate 5'-flanking
region of the hamster DHFR gene. One of these interactions
involves the cellular transcription factor E2F, which binds to

















FIG. 7. A specific site-directed mutation of the DHFR E2F
binding site abolishes efficient in vitro transcription of the DHFR
promoter in HeLa nuclear extracts. Wild-type and E2F mutant -239
constructs (0.5 ,ug) were digested with ScaI to generate linear
templates for in vitro runoff transcription. These templates were
incubated with HeLa nuclear extract in the presence of ribonucle-
otides (including [a2P]GTP), processed, and electrophoresed on 4%
sequencing gels as described in Materials and Methods. A 494-base
Sp6 transcript was included as a control for sample recovery. Lanes:
M, 0X174 HaeIII; WT, 0.5 pLg of wild-type template; MUT, 0.5 iLg
of mutant template. The positions of the marker bands, 494-base
transcript, and DHFR major and minor transcripts are indicated.
transcription start site. The DHFR site possesses dyad
symmetry and includes two potential overlapping E2F bind-
ing sites lying in opposite orientation. A mutation which
abolishes the interaction of E2F with the DHFR promoter
reduces transcription in vitro by two- to fivefold and tran-
sient DHFR-CAT expression in vivo by fivefold. This is the
first demonstration of E2F binding to the DHFR gene and of
the requirement for E2F for efficient DHFR expression.
Several findings suggest that the factor interacting with
this region of the DHFR promoter is E2F. First, the region of
the DHFR promoter protected by this factor in enzymatic
and chemical footprinting experiments contains two recog-
nition sequences for E2F. Second, specific gel shift com-
plexes comigrating with those generated by partially pure
E2F on the DHFR promoter are found in crude nuclear
extracts from HeLa cells. Third, the methylation interfer-
ence analysis of these complexes demonstrates multiple
protein-DNA contacts within the DHFR E2F site. Finally,
the complexes comigrating with partially purified E2F in
HeLa crude nuclear extract can be competed for by an
oligonucleotide containing the DHFR E2F binding site, but
not by an oligonucleotide bearing a mutation of this site
which abolishes the E2F consensus binding site.
The DHFR E2F binding site is unique among reported
E2F binding sites in its location 3' to the transcription start
sites and in its nontandem arrangement. Previously reported
E2F sites within the adenovirus E2 and ElA and the human
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FIG. 8. A specific site-directed mutation of the DHFR E2F
binding site abolishes efficient in vivo expression of the DHFR
promoter in transient-expression assays. HeLa cells in monolayer
were transfected with 10 ,ug of the wild-type -239 construct (lane
WT) or 10 ,ug of mutant -239 construct (lane MUT). The percent
conversion of nonacetylated to acetylated ["4C]chloramphenicol is
indicated below each lane.
c-myc promoters occur in tandem, with conserved spacing
(Table 1). It should be noted that site 1 of the adenovirus
ElA enhancer possesses a dyad symmetry that is similar to
the DHFR site. The DHFR sequence immediately flanking
and including the DHFR E2F site is absolutely conserved in
the hamster, murine, and human DHFR promoters (1),
implying that the structural features of this sequence may be
important in the regulation of DHFR transcription. It is not
entirely unprecedented that a sequence element 3' to the
mRNA cap site is involved in transcriptional regulation (25).
The location of the DHFR E2F site 3' to the major transcrip-
tion start site is interesting in that this sequence, which
exhibits secondary structure in vitro, is represented in both
the major and minor DHFR RNA transcripts. We are
investigating the possibility of an additional role of the E2F
binding site (or factor interacting with this sequence) in
regulating DHFR mRNA stability. In contrast to those of the
human (3) and hamster (18) DHFR promoters, the major
transcription start site in the murine DHFR gene has been
mapped immediately 3' to the DHFR E2F site (7); the
significance of this difference is presently unknown.
The E2F factor may also be involved in the regulation of
DHFR transcription in response to various factors. The
increased expression of DHFR in adenovirus-infected cells
may involve the E2F interaction with the DHFR promoter.
Previous work has suggested that both a transcriptional
activation of DHFR expression (7) and a transient stabiliza-
tion of DHFR transcripts within the nucleus (27) result from
adenovirus infection.
We are also investigating the possible role of E2F in the
regulation of DHFR expression within the cell cycle and in
response to growth stimuli. Cellular ElA-like factors have
been implicated in the activation of E2F (19) and may be
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E2F factor. The following cellular genes that are under
growth control contain E2F sites: c-myc, N-myc, c-myb, and
the EGF receptor gene (M. Mudryj, S. Hiebert, and J.
Nevins, submitted for publication). The c-myc proto-onco-
gene appears to require E2F for basal-level expression and
trans-activation by ElA (10, 24). In the 5' sequence of an
additional growth-regulated gene, the transferrin receptor
gene (17), we have noticed a intragenic E2F binding site.
It is not yet clear whether the observed gel shift complexes
seen with E2F on the DHFR promoter are due to occupancy
of one site or both sites. We are presently constructing
site-directed mutants which abolish each of the E2F binding
sites separately to further examine the interaction of E2F
with the DHFR promoter. Earlier studies of the E2F factor
demonstrated very low binding activity in non-adenovirus-
infected HeLa cells (12, 22). However, we routinely detect
E2F in our binding assays when using extracts from unin-
fected HeLa cells. The reason for this apparent difference is
unknown, although we have modified the extract preparation
procedure.
Functional analysis of the DHFR E2F mutant revealed a
significant reduction in DHFR expression in vitro and in
vivo. Although this mutation reduced transcription two- to
fivefold, the relative ratio of transcripts from the two DHFR
transcription start sites (4:1) and the position of the major
start site remained the same. Therefore, we do not believe
that E2F is required to specify the start site of DHFR
transcription, nor that it affects the relative use of either the
major or minor transcription start sites. It has been sug-
gested that GC boxes may have a role in specifying the start
site for promoters lacking the TATAA sequence element,
and it is possible that interactions at the GC boxes of the
DHFR promoter are responsible for the placement of the
major and minor transcription start sites.
Binding of a factor to the GC boxes within the DHFR
promoter has been shown to be required for DHFR tran-
scription (Swick et al., submitted). We have shown here that
the interaction of E2F with the DHFR promoter is required
for efficient DHFR expression. Additional regions of con-
served DNA sequence within the promoter region may also
have functional importance, and they are currently being
examined by site-directed mutagenesis. Further analysis of
the interactions of E2F, Spl, and additional factors with the
DHFR promoter region will clarify the requirements for
DHFR transcription and regulation.
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